Who Owns Novavax Stock?
NASDAQ: NVAXHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 68.65%
- Held by insiders
- 5.05%
- Institutional holders
- 349
- Institutions 68.6%
- Insiders 5.0%
- Public and other 26.3%
Who owns Novavax stock?
Institutional investors own about 68.6% of Novavax's shares, spread across 349 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 5.05% of NVAX.
The largest institutional holders are Blackrock Inc. (9.45%), Shah Capital Management (7.38%) and State Street Corporation (5.35%). Together, the top 10 institutions control 46.8% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their NVAX positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of NVAX
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Blackrock Inc. | 15.59M | 9.45% | +11.8% |
| Shah Capital Management | 12.17M | 7.38% | -14.1% |
| State Street Corporation | 8.83M | 5.35% | -24.8% |
| Vanguard Portfolio Management LLC | 7.25M | 4.39% | -4.7% |
| Vanguard Capital Management LLC | 7.23M | 4.38% | -0.3% |
| Sanofi | 6.88M | 4.17% | 0.0% |
| Shaw D.E. & Co., Inc. | 5.73M | 3.47% | +1.4% |
| Two Sigma Investments, LP | 5.51M | 3.34% | +34.7% |
| Geode Capital Management, LLC | 4.23M | 2.56% | +0.6% |
| Coatue Management LLC | 3.84M | 2.33% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of NVAX
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 5.20M | 3.15% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 4.60M | 2.79% |
| iShares Trust-iShares Russell 2000 ETF | 3.97M | 2.41% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 3.77M | 2.28% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund | 2.16M | 1.31% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 1.89M | 1.15% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 1.67M | 1.01% |
| iShares Trust-iShares Russell 2000 Value ETF | 1.44M | 0.87% |
| iShares Trust-iShares Biotechnology ETF | 1.22M | 0.74% |
| PIMCO Equity Series-PIMCO RAE US Small Fund | 1.02M | 0.62% |
Frequently asked questions
Who is the largest shareholder of Novavax?
Blackrock Inc. is the largest institutional shareholder of NVAX, owning 9.45% of shares outstanding (15.59M shares) as of its latest 13F filing.
What percentage of Novavax is owned by institutions?
Institutions own about 68.6% of NVAX shares and 72.3% of the public float.
How much of Novavax do insiders own?
Insiders, such as officers and directors, own about 5.05% of NVAX shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.